Alyeska Investment Group’s Protagonist Therapeutics PTGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-50,000
Closed -$1.04M 463
2017
Q4
$1.04M Buy
+50,000
New +$1.04M 0.01% 349